Back
Par Pacific Holdings Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
57
PARR
Par Pacific Holdings
Last Price:
17.63
Seasonality Move:
6.39%
Sell
47
APLS
Apellis Pharmaceuticals
Last Price:
28.64
Seasonality Move:
20.78%
Buy
57
Par Pacific Holdings (PARR)
is a Buy
Is Par Pacific Holdings a Buy, Sell or Hold?
- The current Par Pacific Holdings [PARR] share price is $16.75. The Score for PARR is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PARR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $29.26. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PARR Stock Price Chart
What is Par Pacific Holdings's stock price today?
-
The Par Pacific Holdings share price today is $16.75
The current trend is relatively stagnant and PARR is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $29.26
The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
PARR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 48.54 | Sell |
| Chaikin Money Flow: | -525839 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.9 - 17.7) | Sell |
| Bollinger Bands (100): | (17.59 - 24.21) | Sell |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 52.74 | Buy |
| Chaikin Money Flow: | 179519 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.95 - 28.71) | Buy |
| Bollinger Bands (100): | (29.49 - 39.35) | Sell |
PARR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.07 | Buy |
| 20-day SMA: | 16.54 | Buy |
| 50-day SMA: | 17.87 | Sell |
| 200-day SMA: | 27.1 | Sell |
| 8-day EMA: | 16.3 | Buy |
| 20-day EMA: | 16.62 | Buy |
| 50-day EMA: | 18.13 | Sell |
| 200-day EMA: | 24.31 | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.88 | Buy |
| 20-day SMA: | 28.02 | Buy |
| 50-day SMA: | 30.86 | Sell |
| 200-day SMA: | 43.85 | Sell |
| 8-day EMA: | 28.92 | Buy |
| 20-day EMA: | 28.61 | Buy |
| 50-day EMA: | 30.58 | Sell |
| 200-day EMA: | 40.41 | Sell |
Par Pacific Holdings Earnings Growth & PARR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.73 per share, and an increase next year of $2.52 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Par Pacific Holdings Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||